FDA dismayed by DWP closures - 16 September 2004

The FDA today expressed surprise and dismay at the announcement by the Department for Work and Pensions of closures involving JobCentre Plus and the department's Corporate and Shared Services. The FDA shares the stated aim of the department to manage this reduction without the need for compulsory redundancies or transfers. However, to make this announcement before talks are concluded is premature.

The FDA has been in negotiations with DWP management for some months but firm proposals for dealing with the reduction in posts have yet to be finalised.

Jonathan Baume, FDA general secretary said: "The timing of this announcement is extremely unhelpful. The FDA is committed to working with the department to avoid compulsory redundancies or transfers and making an announcement like this whilst we are engaged in negotiations will only make the task harder. The effect on staff morale in the units being closed will be devastating, especially as no decisions have been taken on redeployment. In many cases these closures affect communities with little alternative employment, making the impact all the more devastating.

"The FDA will continue its dialogue with DWP but the department must now put a real effort into dealing with its staff and representatives in a meaningful way."

Notes for Editors
1. The FDA is the trade union and professional body representing the UK's 11,000 senior civil and public servants. Our members include policy advisors, senior managers, tax inspectors, economists, statisticians, accountants, special advisers, government lawyers, crown prosecutors and NHS managers.
2. For further information contact: